These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20167810)

  • 21. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation.
    Okano J; Gaslightwala I; Birnbaum MJ; Rustgi AK; Nakagawa H
    J Biol Chem; 2000 Oct; 275(40):30934-42. PubMed ID: 10908564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells.
    Yan W; Qian C; Zhao P; Zhang J; Shi L; Qian J; Liu N; Fu Z; Kang C; Pu P; You Y
    Neuro Oncol; 2010 Aug; 12(8):765-75. PubMed ID: 20511184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and therapeutic significance of Akt deregulation in malignant melanoma.
    Robertson GP
    Cancer Metastasis Rev; 2005 Jun; 24(2):273-85. PubMed ID: 15986137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of AKT2 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells.
    Cui Y; Wang Q; Wang J; Dong Y; Luo C; Hu G; Lu Y
    Brain Res; 2012 Aug; 1469():1-9. PubMed ID: 22771706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Akt isoforms are present at distinct subcellular locations.
    Santi SA; Lee H
    Am J Physiol Cell Physiol; 2010 Mar; 298(3):C580-91. PubMed ID: 20018949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissecting signalling by individual Akt/PKB isoforms, three steps at once.
    Osorio-Fuentealba C; Klip A
    Biochem J; 2015 Sep; 470(2):e13-6. PubMed ID: 26348913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines.
    Koseoglu S; Lu Z; Kumar C; Kirschmeier P; Zou J
    Cancer Biol Ther; 2007 May; 6(5):755-62. PubMed ID: 17426444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice.
    Watson KL; Moorehead RA
    BMC Cancer; 2013 Aug; 13():375. PubMed ID: 23919516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies.
    Dummler B; Tschopp O; Hynx D; Yang ZZ; Dirnhofer S; Hemmings BA
    Mol Cell Biol; 2006 Nov; 26(21):8042-51. PubMed ID: 16923958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
    Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of p42.3 in low- and high-grade gliomas.
    Wan W; Xu X; Jia G; Li W; Wang J; Ren T; Wu Z; Zhang J; Zhang L; Lu Y
    World J Surg Oncol; 2014 Jun; 12():185. PubMed ID: 24927751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. K-Ras(V12) differentially affects the three Akt isoforms in lung and pancreatic carcinoma cells and upregulates E-cadherin and NCAM via Akt3.
    Geißert R; Lammert A; Wirth S; Hönig R; Lohfink D; Unger M; Pek D; Schlüter K; Scheftschik T; Smit DJ; Jücker M; Menke A; Giehl K
    Cell Commun Signal; 2024 Jan; 22(1):85. PubMed ID: 38291468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members.
    DeFeo-Jones D; Barnett SF; Fu S; Hancock PJ; Haskell KM; Leander KR; McAvoy E; Robinson RG; Duggan ME; Lindsley CW; Zhao Z; Huber HE; Jones RE
    Mol Cancer Ther; 2005 Feb; 4(2):271-9. PubMed ID: 15713898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Astrocyte elevated gene-1 interacts with Akt isoform 2 to control glioma growth, survival, and pathogenesis.
    Hu B; Emdad L; Bacolod MD; Kegelman TP; Shen XN; Alzubi MA; Das SK; Sarkar D; Fisher PB
    Cancer Res; 2014 Dec; 74(24):7321-32. PubMed ID: 25304263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Akt in human malignant glioma: from oncogenesis to tumor aggressiveness.
    Chautard E; Ouédraogo ZG; Biau J; Verrelle P
    J Neurooncol; 2014 Apr; 117(2):205-15. PubMed ID: 24477623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Fibronectin 1 on Cell Proliferation, Senescence and Apoptosis of Human Glioma Cells Through the PI3K/AKT Signaling Pathway.
    Liao YX; Zhang ZP; Zhao J; Liu JP
    Cell Physiol Biochem; 2018; 48(3):1382-1396. PubMed ID: 30048971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
    Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
    J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Atherosclerosis in Ldl Receptor-Null Mice.
    Babaev VR; Ding L; Zhang Y; May JM; Ramsey SA; Vickers KC; Linton MF
    Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):156-169. PubMed ID: 30567482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.